Boston Scientific sells microsphere business, readies for $4.2B UK acquisition

Written by Alan Condon | July 02, 2019 | Print  |

Varian Medical is purchasing Boston Scientific's microsphere business for $90 million as the Marlborough, Mass.-based medical device company prepares for a $4.2 billion acquisition of BTG, a cancer and vascular disease company, reports Worcester Business Journal.

Three things to know:

1. Varian Medical will acquire Oncozene, Embozene and Embozene Tandem, Boston Scientific's products that treat arteriovenous malformations in the brain and spine.

2. The three products accumulated $21.2 million in sales in 2018.

3. The deal will be completed after Boston Scientific finalizes the acquisition of BTG, expected in August.

More articles on devices:
8 leadership changes in spine, orthopedic device companies in June
Fusion Robotics to advance spinal robotic devices

Alexion drug receives FDA approval for rare autoimmune disease of spinal cord



© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months